Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients

Author： Yeo Winnie  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.88, Iss.3, 2004-12, pp. : 209-215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preemptive use of lamivudine in breast cancer patients carrying hepatitis B virus undergoing cytotoxic chemotherapy: a longitudinal follow-up

By Dai Ming-Shen  

Supportive Care in Cancer, Vol. 12, Iss. 3, 2004-03 ,pp. : 191-196

Springer Publishing Company

Access to resources Recommend Favorite

Hepatitis B Virus Reactivation in Patients Receiving Chemotherapy for Cancer Treatment: Role of Lamivudine Prophylaxis

By Coiffier Bertrand  

Cancer Investigation, Vol. 24, Iss. 5, 2006-06 ,pp. : 548-552

Informa Healthcare

Access to resources Recommend Favorite

Epirubicin directly promotes hepatitis B virus (HBV) replication in stable HBV-expressing cell lines: A novel mechanism of HBV reactivation following anticancer chemotherapy

By                    

Molecular Medicine Reports, Vol. 9, Iss. 4, 2014-01 ,pp. : 1345-1350

Spandidos Publications

Access to resources Recommend Favorite

Intracellular levels of hepatitis B virus DNA and mutational patterns of the polymerase gene of hepatitis B virus in peripheral blood mononuclear cells of patients with lamivudine or telbivudine resistance

By  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 3, 2015-01 ,pp. : 885-890

Spandidos Publications

Access to resources Recommend Favorite

Radiation-induced hepatitis B virus reactivation in hepatocellular carcinoma: A case report

By          

Oncology Letters, Vol. 10, Iss. 5, 2015-01 ,pp. : 3213-3215

Spandidos Publications

Access to resources Recommend Favorite